Takes the reader on a journey through the development of a treatment regimen for multiple myeloma called 'dt Z'. This book presents an account of how more than 50 patients with myeloma were given a non-toxic, precisely-targeted, anti-cancer treatment that was specifically adapted to their individual cancers.